Brain tumors are the leading cause of cancer-related deaths in children, with medulloblastoma relapsing in 30% of cases. Current treatments, developed in the 1980s, often cause severe, lifelong side effects—when survival is even possible.
Now, hope is within reach. Three groundbreaking clinical trials are ready to launch, but $3 million is needed to fund and sustain them. This research could change outcomes for countless children.
You have the power to rewrite their story. Join us in making history—donate today and help save lives. Our goal is to raise $3 million by October 2025.
Give now!
